LipoScience Sets New 12-Month Low at $2.84 (LPDX)
LipoScience (NASDAQ:LPDX) shares reached a new 52-week low on Monday , StockRatingsNetwork.com reports. The company traded as low as $2.84 and last traded at $2.92, with a volume of 28,385 shares trading hands. The stock had previously closed at $2.97.
Separately, analysts at Piper Jaffray cut their price target on shares of LipoScience from $3.80 to $3.25 in a research note on Wednesday, August 13th. They now have a “neutral” rating on the stock.
The stock’s 50-day moving average is $3.20 and its 200-day moving average is $3.48. The company’s market cap is $44.3 million.
LipoScience (NASDAQ:LPDX) last posted its quarterly earnings results on Tuesday, August 12th. The company reported ($0.27) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.24) by $0.03. Analysts expect that LipoScience will post $-0.86 EPS for the current fiscal year.
LipoScience, Inc is a vitro diagnostic company. The Company’s diagnostic test, the nuclear magnetic resonance (NASDAQ:LPDX) LipoProfile test, directly measures the number of low density lipoprotein (LDL), particles in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease.
Receive News & Ratings for LipoScience Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LipoScience Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.